Curating the latest ADC science, clinical data and lessons learned World ADC Berlin will enable you to maximise the clinical therapeutic window of your ADC.
Now in it’s 8th year, World ADC Berlin is Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
Attend World ADC Berlin this year to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialisation. For 2018, 320 drug developers across 140+ active organisations will unite at this industry focussed conference to foster new connections, further develop business relationships and meet with current partners.
Join your peers at Europe’s longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.
“The World ADC meetings organized by Hanson Wade provide for superb networking for the scientific community working on ADCs within Biotech, Pharma and Academia.”
- ImmunoGen, Inc.
“Well organised, great coverage of the presentations. Nice setting for networking”
“The World ADC meeting was again a great platform for scientific exchange with networking at its best.”
- Boehringer Ingelheim